Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients. (Record no. 20784828)

MARC details
000 -LEADER
fixed length control field 01501 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516033924.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201201s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1432-0843
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s00280-011-1650-8
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Rezai, Keyvan
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120111
245 00 - TITLE STATEMENT
Title Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer chemotherapy and pharmacology
Date of publication, distribution, etc. Dec 2011
300 ## - PHYSICAL DESCRIPTION
Extent 1529-36 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lapatinib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maximum Tolerated Dose
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Models, Biological
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vinblastine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vinorelbine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Urien, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Isambert, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roche, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dieras, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Berille, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bonneterre, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brain, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lokiec, F
773 0# - HOST ITEM ENTRY
Title Cancer chemotherapy and pharmacology
Related parts vol. 68
-- no. 6
-- p. 1529-36
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s00280-011-1650-8">https://doi.org/10.1007/s00280-011-1650-8</a>
Public note Available from publisher's website

No items available.